Coronary/Structural Heart

Researchers receive $1.5 million each to study extracellular matrix for cardiovascular research

DALLAS, Aug. 9, 2017 /PRNewswire/ — Two researchers have been awarded grants that could help uncover the next breakthrough in heart-health research, the American Heart Association and The Paul G. Allen Frontiers Group announced Wednesday.  Suneel Apte at the Cleveland Clinic and Jeffrey Holmes at the University of Virginia have been awarded $1.5 million each to study the extracellular matrix […]

CeloNova BioSciences Announces Financing Arrangement with Congruent Investment Partners and SWK Holdings Corporation

CeloNova BioSciences Announces Financing Arrangement with Congruent Investment Partners and SWK Holdings Corporation Proceeds to Support Company Growth, Ongoing Clinical Trial Enrollment and New Product Initiatives CeloNova BioSciences, Inc. (CeloNova), a medical device company that develops, manufactures and markets a family of innovative cardiovascular products based upon its novel Polyzene™-F […]

InspireMD’s Cguard Carotid Embolic Prevention System Featured At The SOLACI CACI Congress Of Cardiology 2017 In Buenos Aires

TEL AVIV, ISRAEL–(Marketwired – August 03, 2017) – InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that an endovascular interventional procedure featuring the CGuard™ EPS performed by the team of Dr. Anibal Damonte, Interventional […]

RTI Surgical® Divests Cardiothoracic Closure Business to A&E Medical Corporation for up to $60 Million

ALACHUA, Fla.–(BUSINESS WIRE)–RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, today announced that it has sold its cardiothoracic closure business to A&E Advanced Closure Systems, LLC (A&E Medical), a leading cardiovascular medical device OEM and a portfolio company of Vance Street Capital LLC, for $54 million in cash […]

Boston Scientific’s Distribution Option Lapses

SAN DIEGO, Aug. 03, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) announces the expiration of Boston Scientific Corporation’s (“BSC”) exclusive right to negotiate for distribution of REVA’s coronary and peripheral bioresorbable scaffolds. BSC’s right to negotiate was available under a 2007 agreement that would have […]

University of Maryland Medicine Establishes Nation’s First Center For Cardiac Xenotransplantation Research With $24 Million Grant And Addition Of Top Transplant Surgeon-Scientists

BALTIMORE, Aug. 3, 2017 /PRNewswire-USNewswire/ —Stephen Bartlett, MD, chair of the Department of Surgery at the University of Maryland School of Medicine, and UM SOMDean E. Albert Reece, MD, PhD, MBA, announced today that a recent $24 million grant from United Therapeutics Corporation will establish the first and only center for cardiac xenotransplantation research in the […]

SHS invests in innovative heart valve-repair start-up CoreMedic

Tuebingen, 27. July 2017. SHS Gesellschaft für Beteiligungsmanagement is investing in CoreMedic, a start-up developing innovative, transfemoral repair systems to treat heart valve malfunctions. SHS is investing from its fourth fund generation to finance CoreMedic’s further growth and the clinical application of its innovative products. Mitral heart valve regurgitation (MR) […]

4C Medical’s Novel Mitral Regurgitation Therapy Highlighted at CVI 2017 Innovation Summit

NEWS PROVIDED BY 4C Medical Technologies, Inc. 07:04 ET BROOKLYN PARK, Minn., Aug. 3, 2017 /PRNewswire/ — 4C Medical Technologies, Inc. (4C Medical), a developer of minimally invasive therapies for structural heart disease, today announced that its medical device therapy for mitral regurgitation (MR) was featured in the Innovation Summit at Cardiovascular Innovations (CVI) 2017 […]

Medtronic (MDT) Bags Approval for Avalus Valve in U.S. and Europe

DUBLIN – August 2, 2017 – Medtronic plc (NYSE: MDT) today announced CE (Conformité Européenne) mark and U.S. Food and Drug Administration (FDA) approval of its new Avalus(TM) pericardial aortic surgical valve for the treatment of aortic valve disease. The Avalus valve leverages proven surgical bioprosthetic valve concepts with added features designed to […]